There are several paths with different timelines for declaring an end to the pandemic. Treatments: A variety of treatments are being explored to attenuate the worst effects of the disease and reduce mortality rates. These include convalescent plasma, antivirals, monoclonal antibodies, and Immune modulators. Remdesivir is FDA approved for Emergency Use but supply is running low. Several antibody treatments could be approved as early as September 2020. Effective treatments and high-volume manufacturing that keep up with demand could dramatically change or curtail the course of COVID-19.More
Is It A Mistake Or Fake News?
Mistakes: Two of the most trusted health organizations,The Center for Disease Control (CDC) and the World Health Organization (WHO) had to retract public statements about the virus that were misleading. Although the main source of COVID-19 transmission is from person to person, the CDC had to amend guidelines updated on May 20th, 2020 that falsely claimed infection from contaminated surfaces is rare. We do not yet know how easily infection occurs from touching contaminated surfaces, so continue using hand sanitizer and washing hands for 20 seconds. The WHO also had to walk back a false statement on June 8, 2020 that asymptomatic transmission is rare. We do not know how much of viral spread is caused by asymptomatic or presymptomatic individuals and studies published the week prior indicate rates of asymptomatic transmission could be relatively high.More
Research & News
A new report shows wearing face masks saves thousands of lives, pointing to the prevalence of airborne transmission and the importance of this public health measure. The virus is spreading among fruit and vegetable packers and farm workers, worrying U.S. officials about labor shortages and disruption to the supply chain. The United States surpasses 2 million COVID-19 cases. An early report of 2000 patients showed a possible increased risk of complications arising from COVID-19 infection for those with an A-positive blood type and a possible protective effect for people with blood type O.More
Who’s Catching it? Will I Get Seriously Ill?
Seniors and those with underlying medical conditions, including 5 pre-existing conditions are considered most at risk for developing serious complications from the virus. People of color are also disproportionately impacted by COVID-19. Many social determinants of health are key drivers of health inequalities. Some examples of social determinants of health include: Increased likelihood of working jobs considered “essential” which increases risk of exposure. Tendency to live in multigenerational households in densely populated areas which makes social distancing difficult. Under-representation in biomedical research. Disproportionate vulnerability to comorbidities due to impaired access to healthcare facilities and grocery stores with nutritious food options. Overrepresentation in jails, prisons, and detention centers. For these reasons, counties and states are introducing measuresMore
Treatments & Vaccines
Treatments: On May 1, 2020, the FDA granted an Emergency Use Authorization (EUA) for medical professionals to treat coronavirus patients with the broad-spectrum antiviral medication, remdesivir. On April 24, 2020, the FDA announced that a previously granted EUA of hydroxychloroquine and chloroquine, which was previously granted EUA, could cause heart problems. Do not take non-pharmaceutical chloroquine phosphate or ingest or inject any disinfectants. Do not take medication to treat coronavirus that has not been prescribed by your healthcare provider for this explicit purpose. Investigational treatments include blood plasma from recently recovered coronavirus patients and an early tuberculosis vaccine. Most people who become infected with COVID-19 have mild symptoms and can recover safely at home.More